Wong J, Hird A, Kirou-Mauro A, Napolskikh J, Chow E. Quality of life in brain metastases radiation trials: a literature review. Curr Oncol. 2008;15(5):25–45.

Article  CAS  Google Scholar 

Liu Q, Tong X, Wang J. Management of brain metastases: history and the present. Chin Neurosurg J. 2019;5(1):1. https://doi.org/10.1186/s41016-018-0149-0.

Article  PubMed  PubMed Central  Google Scholar 

Nasioudis D, Persaud A, Taunk NK, Latif NA. Brain metastases from gynecologic malignancies: prevalence and management. Am J Clin Oncol. 2020;43(6):418–21. https://doi.org/10.1097/COC.0000000000000689.

Article  PubMed  Google Scholar 

Silvestre J, Gosse T, Read P, et al. Genesis of Quality Measurements to Improve the Care Delivered to Patients With Brain Metastases. JCO Oncol Pract. 2021;17(3):e397–405. https://doi.org/10.1200/OP.20.00233.

Article  PubMed  Google Scholar 

Kurra V, Krajewski KM, Jagannathan J, Giardino A, Berlin S, Ramaiya N. Typical and atypical metastatic sites of recurrent endometrial carcinoma. Cancer Imaging. 2013;13(1):113–22. https://doi.org/10.1102/1470-7330.2013.0011.

Article  PubMed  PubMed Central  Google Scholar 

Gavrilovic IT, Posner JB. Brain metastases: epidemiology and pathophysiology. J Neurooncol. 2005;75(1):5–14. https://doi.org/10.1007/s11060-004-8093-6.

Article  PubMed  Google Scholar 

Borella F, Bertero L, Morrone A, et al. Brain metastases from ovarian cancer: current evidence in diagnosis, treatment, and prognosis. Cancers (Basel). 2020;12(8):2156. https://doi.org/10.3390/cancers12082156.

Article  CAS  PubMed Central  Google Scholar 

Pakneshan S, Safarpour D, Tavassoli F, Jabbari B. Brain metastasis from ovarian cancer: a systematic review. J Neurooncol. 2014;119(1):1–6. https://doi.org/10.1007/s11060-014-1447-9.

Article  PubMed  Google Scholar 

Pietzner K, Oskay-Oezcelik G, Khalfaoui KE, Boehmer D, Lichtenegger W, Sehouli J. Brain metastases from epithelial ovarian cancer: overview and optimal management. Anticancer Research. Published online 2009:6.

Stasenko M, Cybulska P, Feit N, et al. Brain metastasis in epithelial ovarian cancer by BRCA1/2 mutation status. Gynecol Oncol. 2019;154(1):144–9. https://doi.org/10.1016/j.ygyno.2019.05.004.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fetcko K, Gondim DD, Bonnin JM, Dey M. Cervical cancer metastasis to the brain: a case report and review of literature. Surg Neurol Int. 2017;8:181. https://doi.org/10.4103/sni.sni_111_17.

Article  PubMed  PubMed Central  Google Scholar 

Branch BC, Henry J, Vecil GG. Brain metastases from cervical cancer – a short review. Tumori. 2014;100(5):e171–9. https://doi.org/10.1700/1660.18186.

Article  PubMed  Google Scholar 

Achrol AS, Rennert RC, Anders C, et al. Brain metastases. Nat Rev Dis Primers. 2019;5(1):5. https://doi.org/10.1038/s41572-018-0055-y.

Article  PubMed  Google Scholar 

Marchetti C, Ferrandina G, Cormio G, et al. Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19). Gynecol Oncol. 2016;143(3):532–8. https://doi.org/10.1016/j.ygyno.2016.09.025.

Article  PubMed  Google Scholar 

Norden AD, Pope WB, Chang SM. Current concepts in brain tumor imaging. Am Soc Clin Oncol Educ Book. 2012;(32):119–24. https://doi.org/10.14694/EdBook_AM.2012.32.119.

Balériaux D, Colosimo C, Ruscalleda J, et al. Magnetic resonance imaging of metastatic disease to the brain with gadobenate dimeglumine. Neuroradiology. 2002;44(3):191–203. https://doi.org/10.1007/s002340100636.

Article  PubMed  Google Scholar 

Ghadimi M, Sapra A. Magnetic Resonance Imaging Contraindications. In: StatPearls. StatPearls Publishing; 2022. http://www.ncbi.nlm.nih.gov/books/NBK551669/. Accessed 22 May 2022.

Fink KR, Fink JR. Imaging of brain metastases. Surg Neurol Int. 2013;4(Suppl 4):S209–19. https://doi.org/10.4103/2152-7806.111298.

Article  PubMed  PubMed Central  Google Scholar 

Langleben DD, Segall GM. PET in differentiation of recurrent brain tumor from radiation injury*. J Nucl Med. 2000;41(11):1861–7.

CAS  PubMed  Google Scholar 

Xi S, Li Z, Guo Q, Lin W, Liang X, Ma L. Prognostic factors among brain metastases in newly diagnosed ovary cancer: a large real-world study. J Cancer. 2020;11(15):4625–40. https://doi.org/10.7150/jca.44494.

Article  PubMed  PubMed Central  Google Scholar 

Kim YZ, Kwon JH, Lim S. A clinical analysis of brain metastasis in gynecologic cancer: a retrospective multi-institute analysis. J Korean Med Sci. 2015;30(1):66–73. https://doi.org/10.3346/jkms.2015.30.1.66.

Article  PubMed  Google Scholar 

Mahmoud-Ahmed AS, Kupelian PA, Reddy CA, Suh JH. Brain metastases from gynecological cancers: factors that affect overall survival. Technol Cancer Res Treat. 2002;1(4):305–10. https://doi.org/10.1177/153303460200100412.

Article  PubMed  Google Scholar 

Kim H, Lee KK, Heo MH, Kim JY. The prognostic factors influencing overall survival in uterine cervical cancer with brain metastasis. Korean J Intern Med. 2019;34(6):1324–32. https://doi.org/10.3904/kjim.2018.051.

Article  PubMed  Google Scholar 

Cagino K, Kahn R, Pannullo S, et al. Treatment patterns and outcomes among women with brain metastases from gynecologic malignancies. Gynecol Oncol Rep. 2020;34:100664. https://doi.org/10.1016/j.gore.2020.100664.

Article  PubMed  PubMed Central  Google Scholar 

Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37(4):745–51. https://doi.org/10.1016/s0360-3016(96)00619-0.

Article  CAS  PubMed  Google Scholar 

Soffietti R, Cornu P, Delattre JY, et al. EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. Eur J Neurol. 2006;13(7):674–81. https://doi.org/10.1111/j.1468-1331.2006.01506.x.

Article  CAS  PubMed  Google Scholar 

Chang SM, Messersmith H, Ahluwalia M, et al. Anticonvulsant Prophylaxis and Steroid Use in Adults With Metastatic Brain Tumors: ASCO and SNO Endorsement of the Congress of Neurological Surgeons Guidelines. JCO. 2019;37(13):1130-1135. https://doi.org/10.1200/JCO.18.02085. Article discussing current strategies on symptom control secondary to brain metastases.

Glantz MJ, Cole BF, Forsyth PA, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;54(10):1886–93. https://doi.org/10.1212/wnl.54.10.1886.

Article  CAS  PubMed  Google Scholar 

Gondi V, Bauman G, Bradfield L, et al. Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline. Pract Radiat Oncol. 2022;0(0). https://doi.org/10.1016/j.prro.2022.02.003. Review article aimed at radiation oncologist giving treatment algorithms for a multidisciplinary approach.

Fugate JE. Complications of Neurosurgery: CONTINUUM: Lifelong Learning in Neurology. 2015;21:1425-1444. https://doi.org/10.1212/CON.0000000000000227.

Wilhelm I, Molnár J, Fazakas C, Haskó J, Krizbai IA. Role of the blood-brain barrier in the formation of brain metastases. Int J Mol Sci. 2013;14(1):1383–411. https://doi.org/10.3390/ijms14011383.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nieder C, Grosu AL, Astner S, Thamm R, Molls M. Integration of chemotherapy into current treatment strategies for brain metastases from solid tumors. Radiat Oncol. 2006;1:19. https://doi.org/10.1186/1748-717X-1-19.

Article  PubMed  PubMed Central  Google Scholar 

Fellner S, Bauer B, Miller DS, et al. Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo. J Clin Invest. 2002;110(9):1309–18. https://doi.org/10.1172/JCI15451.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun K, Mikule K, Wang Z, et al. A comparative pharmacokinetic study of PARP inhibitors demonstrates favorable properties for niraparib efficacy in preclinical tumor models. Oncotarget. 2018;9(98):37080-37096. https://doi.org/10.18632/oncotarget.26354

Wang Q, Zhang F, Gao H, Xu Y. Successful treatment of a patient with brain metastases from endometrial cancer using Niraparib: a case report. Ann Palliat Med. 2021;10(1):81827-81827. https://doi.org/10.21037/apm-21-113

Bangham M, Goldstein R, Walton H, Ledermann JA. Olaparib treatment for BRCA-mutant ovarian cancer with leptomeningeal disease. Gynecol Oncol Rep. 2016;18:22–4. https://doi.org/10.1016/j.gore.2016.10.004.

Article  PubMed  PubMed Central  Google Scholar 

Carruthers R, Chalmers AJ. The potential of PARP inhibitors in neuro-oncology. CNS Oncol. 2012;1(1):85–97. https://doi.org/10.2217/cns.12.13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiangying M, Rugang Z, Lijuan D, et al. Low-dose bevacizumab as an effective pre-treatment for peri-tumoral brain edema prior to CyberKnife radiosurgery: a case report. Cancer Biol Ther. 2018;19(6):461–4. https://doi.org/10.1080/15384047.2018.1433499.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mulvenna P, Nankivell M, Barton R, et al. Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial. Lancet. 2016;388(10055):2004-2014. https://doi.org/10.1016/S0140-6736(16)30825-X. Randomized phase III trial looking at supportive care and whole brain radiation therapy in patients with poor prognosis.

Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA. 1998;280(17):1485–9. https://doi.org/10.1001/jama.280.17.1485.

Article  CAS  PubMed  Google Scholar 

Kocher M, Soffietti R, Abacioglu U, et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 Study. JCO. 2011;29(2):134–41. https://doi.org/10.1200/JCO.2010.30.1655.

Article  Google Scholar 

Mahajan A, Ahmed S, McAleer MF, et al. Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol. 2017;18(8):1040–8. https://doi.org/10.1016/S1470-2045(17)30414-X.

Article  PubMed  PubMed Central  Google Scholar 

Brown PD, Ballman KV, Cerhan JH, et al. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol. 2017;18(8):1049–60. https://doi.org/10.1016/S1470-2045(17)30441-2.

Article  PubMed  PubMed Central